CLEARONE INC (CLRO)

US18506U1043 - Common Stock

1.05  -0.03 (-2.78%)

After market: 1.1 +0.05 (+4.76%)

Fundamental Rating

4

CLRO gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 54 industry peers in the Communications Equipment industry. CLRO has a great financial health rating, but its profitability evaluates not so good. CLRO is valued expensive and it does not seem to be growing.



2

1. Profitability

1.1 Basic Checks

CLRO had negative earnings in the past year.
In the past year CLRO had a positive cash flow from operations.
In multiple years CLRO reported negative net income over the last 5 years.
CLRO had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

CLRO's Return On Assets of -1.10% is in line compared to the rest of the industry. CLRO outperforms 57.41% of its industry peers.
CLRO has a better Return On Equity (-1.25%) than 62.96% of its industry peers.
Industry RankSector Rank
ROA -1.1%
ROE -1.25%
ROIC N/A
ROA(3y)3.94%
ROA(5y)-0.52%
ROE(3y)3.85%
ROE(5y)-1.27%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 34.05%, CLRO perfoms like the industry average, outperforming 40.74% of the companies in the same industry.
In the last couple of years the Gross Margin of CLRO has declined.
CLRO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 34.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.69%
GM growth 5Y-6.47%

8

2. Health

2.1 Basic Checks

CLRO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CLRO has about the same amount of shares outstanding.
CLRO has more shares outstanding than it did 5 years ago.
CLRO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

CLRO has an Altman-Z score of 3.34. This indicates that CLRO is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.34, CLRO is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
There is no outstanding debt for CLRO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.34
ROIC/WACCN/A
WACC9.91%

2.3 Liquidity

CLRO has a Current Ratio of 10.16. This indicates that CLRO is financially healthy and has no problem in meeting its short term obligations.
CLRO has a better Current ratio (10.16) than 94.44% of its industry peers.
A Quick Ratio of 7.67 indicates that CLRO has no problem at all paying its short term obligations.
The Quick ratio of CLRO (7.67) is better than 98.15% of its industry peers.
Industry RankSector Rank
Current Ratio 10.16
Quick Ratio 7.67

0

3. Growth

3.1 Past

The earnings per share for CLRO have decreased strongly by -102.86% in the last year.
CLRO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -25.81%.
CLRO shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -7.86% yearly.
EPS 1Y (TTM)-102.86%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-86.72%
Revenue 1Y (TTM)-25.81%
Revenue growth 3Y-13.67%
Revenue growth 5Y-7.86%
Revenue growth Q2Q3.33%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CLRO. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

CLRO's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CLRO is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.47
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 142.86%, CLRO is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 15.50, CLRO pays a better dividend. On top of this CLRO pays more dividend than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, CLRO pays a better dividend.
Industry RankSector Rank
Dividend Yield 142.86%

5.2 History

The dividend of CLRO is nicely growing with an annual growth rate of 50.73%!
CLRO has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)50.73%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

CLRO has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-5193.37%
EPS Next 2YN/A
EPS Next 3YN/A

CLEARONE INC

NASDAQ:CLRO (5/3/2024, 7:00:00 PM)

After market: 1.1 +0.05 (+4.76%)

1.05

-0.03 (-2.78%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap25.17M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 142.86%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.1%
ROE -1.25%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 34.05%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 10.16
Quick Ratio 7.67
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-102.86%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-25.81%
Revenue growth 3Y-13.67%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y